Director Hudson Blake Leogrande disclosed a change in beneficial ownership of Prenetics Global Ltd (NASDAQ: PRE) Class A Ordinary Shares following the settlement of vested Restricted Stock Units, with the filing dated August 5, 2026.

Key Highlights

  • Reporting person: Hudson Blake Leogrande, identified as a Director of Prenetics Global Ltd.
  • Transaction date: The transaction occurred on August 4, 2026.
  • Shares acquired: 2,001 Class A Ordinary Shares, par value $0.0015 per share, were acquired at a price of $0 upon RSU settlement.
  • Post-transaction ownership: Following the transaction, Leogrande directly holds 4,001 Class A Ordinary Shares.
  • RSU vesting date: The 2,001 RSUs underlying the settlement vested on June 4, 2026, according to the filing.
  • Remaining RSUs: Leogrande retains 20,003 Restricted Stock Units with an expiration date of June 4, 2032.

Prenetics Global Director Leogrande Settles Vested RSUs Under 2022 Share Incentive Plan

According to the filing, Hudson Blake Leogrande, a Director of Prenetics Global Ltd (NASDAQ: PRE), reported the acquisition of 2,001 Class A Ordinary Shares, par value $0.0015 per share, on August 4, 2026. The filing describes these shares as having been "issued and delivered upon settlement of vested Restricted Stock Units ('RSUs') granted under the Issuer's 2022 Share Incentive Plan." The acquisition was recorded under transaction code M, indicating an exercise or conversion of a derivative security, at a price of $0.

Prenetics Global Ltd is the issuer of the Class A Ordinary Shares involved in this transaction, and the RSUs were granted under the company's 2022 Share Incentive Plan. The filing states that each RSU "represents a contingent right to receive one Class A Ordinary Share" and that the 2,001 RSUs included in this settlement vested on June 4, 2026. Prior to this transaction, the director held 2,000 Class A Ordinary Shares directly; the settlement brought that total to 4,001 shares held directly.

In addition to the settled RSUs, the filing reports that Leogrande continues to hold 20,003 Restricted Stock Units with a conversion price of $0, each convertible into one Class A Ordinary Share, and an expiration date of June 4, 2032. The filing was signed by Stephen Hoi Chun Lo as attorney-in-fact for Hudson Blake Leogrande on August 5, 2026, and states the filing was made by one reporting person.

What Was Disclosed

The filing reported the settlement of 2,001 vested RSUs into an equal number of Class A Ordinary Shares of Prenetics Global Ltd under the company's 2022 Share Incentive Plan, bringing the director's direct share total to 4,001, while 20,003 RSUs remain outstanding.